Drawing for NUNTIUS

USPTO serial 99469765

NUNTIUS

Reviewed by CopyMark Law Group

Status 807Office Action
Filing date
Status date
Registration date
—
Examiner
EVANKO, PATRICIA MALESARDI
Law office
TMO LAW OFFICE 119

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Need help with NUNTIUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
003Cosmetic products taken orally, namely, pills that induce bronzing of the skin; Nasal cleaning preparations for personal sanitary purposes; Topical skin sprays for cosmetic purposes; Wrinkle-minimizing cosmetic preparations for topical facial use; Topical herbal cream for firming and enhancing breasts; Skin and body topical lotions, creams and oils for cosmetic useACTIVEJul 15, 2026
005Oral analgesics; Medicated oral care gels; Medicated brush-on oral care gels; Oral spray for the cessation of smoking; Ibuprofen for use as an oral analgesic; Nasal and oral spray preparations for use as central nervous system stimulants; Materials for crowns and bridges for dental use and for oral prophylaxis; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Nasal rinse; Nasal spray preparations; Nasal sprays for medical purposes; Nasal cleaning preparations for medical purposes; Nasal drops for the treatment of allergies; Saline solution for sinus and nasal irrigation; Concentrated saline capsules for sinus and nasal irrigation; Dry ingredients for making a saline solution for sinus and nasal irrigation; Pharmaceutical preparations, namely, dantrolene sodium for injection; Topical anesthetics; Topical analgesics; Topical analgesic creams; Alcohol for topical use; Topical first aid gel; Topical dermatological preparations that treat insect bites and stings; Topical gel for medical and therapeutic use, namely, ultrasound gel; Non-medicated topical gel for the prevention and treatment of allergies; Fluid for the topical fluoridation of tooth enamel and decay prevention; Non-medicated topical gel for the prevention and treatment of cold and flu; Medicated topical solution that increases the efficacy and percutaneous absorption of benzoyl peroxide; Topical gel for medical and therapeutic treatment of sprains, strains, fracture, osteoarthritis, osteoporosis, decay, PAD, neuropathy.; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Intravenous bags sold filled with botanical compoundsACTIVEJul 15, 2026

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (GNRN): A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

DateCodeEventWhat it means
Sep 15, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 15, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 15, 2026CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 2, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 25, 2026IUAFUSE AMENDMENT FILED—
Jul 24, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 26, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 31, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 31, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 25, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 7, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 7, 2026DOCKASSIGNED TO EXAMINER—
Feb 11, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 29, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 29, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance